Update on Disease-Modifying Pharmacological Treatments for Frontotemporal Dementia (FTD): A Scoping Review of Registered Trials. [PDF]
Bartoshyk P, O'Caoimh R.
europepmc +1 more source
Age-Dependent Systemic Regulation of C1q/TNF-Related Protein 3 and Progranulin in Patients with Cystic Fibrosis: Biomarkers or Therapeutic Targets? [PDF]
Schmid A +5 more
europepmc +1 more source
Tissue-specific immune and MAPK signatures in models of reduced Progranulin and Western diet. [PDF]
Merchak AR +10 more
europepmc +1 more source
Dysregulation of adipokines in the serum of breast cancer patients - role in pathogenesis and potential clinical application (preliminary studies). [PDF]
Morawiec ML +3 more
europepmc +1 more source
Exploring the Prognostic Role of Neurofilaments and SEMA3A in Multiple Sclerosis Progression. [PDF]
Pavelek Z +7 more
europepmc +1 more source
Fluid biomarkers in familial frontotemporal dementia: progress and prospects. [PDF]
Guo M +8 more
europepmc +1 more source
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies [PDF]
et al.,, Karch, Celeste M, Wen, Natalie
core +1 more source
Amniotic and cervical fluids progranulin levels in pregnancies complicated by spontaneous preterm delivery with respect to intra-amniotic complications-a retrospective cohort study. [PDF]
Soucek O +7 more
europepmc +1 more source
Time-dependent integrated tissue and circulating biomarker dynamics of spexin and progranulin in an experimental myocardial infarction model. [PDF]
Kaya S, Yalçin T.
europepmc +1 more source
Protein network analysis reveals selectively vulnerable regions and biological processes in FTD [PDF]
Karch, Celeste M. +2 more
core +1 more source

